Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
| ▸ | NPY4R | P50391 | 10/20 | 0.36 |
| ▸ | NPY1R | P25929 | 7/20 | 0.36 |
| ▸ | NPY2R | P49146 | 5/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.35 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.35 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.35 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.34 |
| ▸ | RRM1 | P23921 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21096857 | 0.86 | SIRT6 (0.38) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL19487472 | 0.85 | ALOX15 (0.39) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL29888878 | 0.85 | FOLH1 (0.43) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL350358 | 0.85 | FOLH1 (0.43) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL18356744 | 0.85 | ALOX15 (0.39) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL8663352 | 0.85 | FOLH1 (0.43) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL25857221 | 0.84 | NPY4R (0.42) | SIRT6SIRT1NPY4RNPY1RNPY2R | |
| SCHEMBL27115457 | 0.83 | DPP7 (0.50) | SIRT6SIRT1DPP7GNAI3GNAO1 | |
| SCHEMBL24531193 | 0.83 | C3AR1 (0.38) | MEN1KMT2ASIRT6SIRT1DPP7 | |
| SCHEMBL30483974 | 0.83 | NPY4R (0.53) | SIRT6SIRT1NPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220193210-A1 | THERAPEUTICS FOR AUTOIMMUNE KIDNEY DISEASE: SYNTHETIC ANTIGENS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2022-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193210-A1 | THERAPEUTICS FOR AUTOIMMUNE KIDNEY DISEASE: SYNTHETIC ANTIGENS | SSB, HAVCR2, CD47 | ALOX15 3289/4885MEN1 1723/4885CYP1A2 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.